Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

Erectile dysfunction in men may signal early kidney disease. A doctor explains the connection, warning signs, risk factors, and why timely medical evaluation matters.

Let’s get real for a sec. When men think about turning back the clock - it’s not wrinkles, but the passionate love and fire in the bed. Yeah, that one. The Phoenix ED Device promises exactly that: a ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting ...

Detailed price information for Can-Fite Biopharma Ltd ADR (CANF-A) from The Globe and Mail including charting and trades.

Men visit Planned Parenthood for vital health services such as vasectomy care, STI testing, cancer screening and sexual health counseling. However, policy shifts have placed some of these essential ...

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

In locally recurrent rectal cancer, neoadjuvant chemo-reirradiation plus surgery with IOERT showed no grade 4–5 toxicities ...

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

That wide-ranging impact is why Popular Science chose the drops as the 2025 Health category winner. This year’s list also ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3.0 and $105.0 for Hims & Hers Health, spanning the last three ...